drugset / Trial / NCT03824457
Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia
RandomizedParallel-groupSingle-blindTreatment
Summary
This study evaluates the efficacy and safety of Rheosorbilact®, solution for infusion ("Yuria-Pharm" LLC), in comparison with Ringer's Lactate, solution for infusion, in a complex therapy of pneumonia. Half of participants will receive Rheosorbilact® in complex therapy, while the other half will receive Ringer's Lactate in complex therapy.
Timeline
- Start
- 2018-01-08
- Primary completion
- 2020-02-17
- Completion
- 2020-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rheosorbilact® | Unknown | 400 ml | Intravenous |
| Comparator | Ringer lactate | Other / unclassified | 400 ml | Intravenous |